FADS6
Fatty acid desaturase 6
Also known as: FADS6_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8N9I5
- Gene
- FADS6
- Canonical length
- 356 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for FADS6 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
356 residues, UniProt reviewed canonical sequence.
>Q8N9I5|FADS6
1 MEPTEPMEPT EPMEPTEPME PARSAHRGGE ALLRELEVLV QDVVRTSSWW ERHGVDCAIL
61 ALSLFALPAG FLCLRWENAL VFASGITILG VCHYTLTVKG SHLATHGALT ESKRWSKIWL
121 LFFVEVCTAF TAEHATHGHV KMHHAYTNVV GLGDSSTWRL PCLNRYVYMF LAPFLLPIAT
181 PLVAVERLRK VELGTALRTL ALISLGLYSH YWLLLNVSGF KNPSSALGCM FLTRSLLAHP
241 YLHVNIFQHI GLPMFSRDNK PRRIHMMSLG VLNLARLPVL DWAFGHSIIS CHVEHHLFPR
301 LSDNMCLKVK PVVSQFLREK QLPYNEDSYL ARFQLFLRRY EEFMVQAPPI TELVGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FADS6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 17 nTPM
- small intestine: 13 nTPM
- cerebellum: 12 nTPM
- duodenum: 7 nTPM
- skin: 6.8 nTPM
- adrenal gland: 6.5 nTPM
Single-cell type
- enterocytes: 91 nCPM
- epididymal principal cells: 36 nCPM
- adrenal cortex cells: 18 nCPM
- retinal amacrine cells: 8.4 nCPM
- esophageal suprabasal cells: 7.9 nCPM
- brain excitatory neurons: 7.4 nCPM
Immune cell
- neutrophil: 1.7 nTPM
- non-classical monocyte: 1.3 nTPM
- basophil: 1.1 nTPM
- NK-cell: 0.7 nTPM
- intermediate monocyte: 0.6 nTPM
- classical monocyte: 0.5 nTPM
Brain region
- pons: 40 nTPM
- cerebral cortex: 37 nTPM
- cerebellum: 31 nTPM
- medulla oblongata: 30 nTPM
- thalamus: 29 nTPM
- basal ganglia: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water
- oxidoreductase activity
- acting on paired donors
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FADS6 as an antibody target. Whether an autoantibody or antibody against FADS6 could matter depends on whether native FADS6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FADS6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FADS6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...